The revised DGPPN and APA schizophrenia guidelines: Guideline quality and recommendations for long-term antipsychotic treatment

被引：3
作者：
Gaebel, Wolfgang [1 ,2 ]
Stricker, Johannes [1 ,2 ]
Hasan, Alkomiet [3 ]
Falkai, Peter [4 ]
McIntyre, John S. [5 ]
Kerst, Ariane [1 ,2 ]
机构：
[1] Heinrich Heine Univ, LVR Klinikum Dusseldorf, Med Fac, Dept Psychiat & Psychotherapy, Dusseldorf, Germany
[2] WHO Collaborating Ctr Qual Assurance & Empowermen, Dusseldorf, Germany
[3] Univ Augsburg, Med Fac, Bezirkskrankenhaus Augsburg, Dept Psychiat Psychotherapy & Psychosomat, Augsburg, Germany
[4] Univ Hosp LMU Munich, Dept Psychiat & Psychotherapy, Munich, Germany
[5] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA
来源：
SCHIZOPHRENIA RESEARCH | 2021年 / 229卷
关键词：
Antipsychotic; Guideline; Long-term; Maintenance; Quality; Schizophrenia;
D O I：
10.1016/j.schres.2020.11.011
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
[No abstract available]
引用
收藏
页码：137 / 139
页数：3
相关论文
共 50 条
  • [21] LONG-TERM TREATMENT OF MOOD DISORDERS IN SCHIZOPHRENIA
    AZORIN, JM
    ACTA PSYCHIATRICA SCANDINAVICA, 1995, 91 : 20 - 23
  • [22] New antipsychotics in long-term treatment of schizophrenia
    Möller, HJ
    PSYCHOPHARMAKOTHERAPIE, 2004, 11 (01): : 2 - 10
  • [23] The effect of long-term antipsychotic treatment on the body weight of patients suffering from chronic schizophrenia: clozapine versus classical antipsychotic agents
    Spivak, B
    Musin, E
    Mester, R
    Gonen, N
    Talmon, Y
    Guy, N
    Roitman, S
    Kupchik, M
    Kotler, M
    Weizman, A
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1999, 14 (04) : 229 - 232
  • [24] Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies
    Murasaki, Mitsukuni
    Inoue, Yoshifumi
    Nakamura, Hiroshi
    Kinoshita, Toshihiko
    ANNALS OF GENERAL PSYCHIATRY, 2021, 20 (01)
  • [25] Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies
    Mitsukuni Murasaki
    Yoshifumi Inoue
    Hiroshi Nakamura
    Toshihiko Kinoshita
    Annals of General Psychiatry, 20
  • [26] Long-term antipsychotic use and its association with outcomes in schizophrenia - the Northern Finland Birth Cohort 1966
    Moilanen, J. M.
    Haapea, M.
    Jaaskelainen, E.
    Veijola, J. M.
    Isohanni, M. K.
    Koponen, H. J.
    Miettunen, J.
    EUROPEAN PSYCHIATRY, 2016, 36 : 7 - 14
  • [27] Sustained drug delivery optimizes long-term treatment of patients with schizophrenia
    Chue, PS
    D'Hoore, P
    Ramstack, JM
    ACTA NEUROPSYCHIATRICA, 2004, 16 (06): : 319 - 325
  • [28] Efficacy of aripiprazole (amdoal) in the long-term treatment of schizophrenia
    Tsukarzi, E. E.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (03) : 94 - 97
  • [29] RISK FACTORS FOR NONCOMPLIANCE WITH ANTIPSYCHOTIC MEDICATION IN LONG-TERM TREATED CHRONIC SCHIZOPHRENIA PATIENTS
    Krzystanek, Marek
    Krysta, Krzysztof
    Janas-Kozik, Malgorzata
    Martyniak, Ewa
    Rybakowski, Janusz
    PSYCHIATRIA DANUBINA, 2019, 31 : S543 - S548
  • [30] A critical analysis of recent data on the long-term outcome of antipsychotic treatment
    Moncrieff, Joanna
    Steingard, Sandra
    PSYCHOLOGICAL MEDICINE, 2019, 49 (05) : 750 - 753
12345